OV market is max $100M globally, maybe. Some sources say US market is as low as $8M. If that is the case, IMU have paid more money running an OV trial than the OV market is worth in the US.
Hervaxx and PD1vaxx are basically worthless.
CF33 forms the backbone of three programs. If VAXINA continues to fail as an IT therapy, everything else falls like dominos. Cholangiocarcinoma is a rare cancer and is only receiving attention because it is all you have.
You don't get $500M MC from 1 CR and hope.
From the Professor..., page-83
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |